Literature DB >> 26377127

Influence of the Ring Size on the Binding Ability of FTO Investigated by Fluorescence Spectroscopy.

Wu He1, Zhigang Li1, Lingling Yang1, Qingwei Jiang1, Ting Ren1, Lijiao Zhang1, Zhenhua Shen1, Qinghua Yang1, Ruiyong Wang2, Junbiao Chang3.   

Abstract

The fat mass and obesity associated protein (FTO) is a potential target for anti-obesity medicines. In this paper, we have synthesized two potential inhibitors for FTO, three-member-ring compound (W 3 ) and four-member-ring compound (W 4 ). The interactions of fat mass and obesity-associated (FTO) protein with W 3 (or W 4 ) have been studied by spectral method. Results show the intrinsic fluorescence is quenched by the W 3 (or W 4 ). The thermodynamics parameters indicate hydrophobic interaction play a major role in the interactions. The results of synchronous fluorescence spectra demonstrate that the microenvironments of Trp residue of FTO are disturbed by W 3 and W 4 . Results showed that W 3 are stronger quenchers and bind to FTO with the higher affinity than W 4 . The influence of molecular structure on the binding aspects has been investigated.

Entities:  

Keywords:  Binding; FTO; Fluorescence; Four-member-ring compound; Three-member-ring compound

Mesh:

Substances:

Year:  2015        PMID: 26377127     DOI: 10.1007/s10895-015-1652-8

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  25 in total

1.  A spectroscopic investigations of anticancer drugs binding to bovine serum albumin.

Authors:  S Bakkialakshmi; D Chandrakala
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2011-11-18       Impact factor: 4.098

2.  Investigation of the binding between pepsin and nucleoside analogs by spectroscopy and molecular simulation.

Authors:  Zhen Li; Zhigang Li; Lingling Yang; Yuanzhe Xie; Jie Shi; Ruiyong Wang; Junbiao Chang
Journal:  J Fluoresc       Date:  2015-02-27       Impact factor: 2.217

3.  Characterization of the interaction between 8-bromoadenosine with human serum albumin and its analytical application.

Authors:  Fengling Cui; Yinghua Yan; Qiangzhai Zhang; Xiaojun Yao; Guirong Qu; Yan Lu
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2009-09-08       Impact factor: 4.098

4.  Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor.

Authors:  Baoen Chen; Fei Ye; Lu Yu; Guifang Jia; Xiaotian Huang; Xueju Zhang; Shuying Peng; Kai Chen; Meining Wang; Shouze Gong; Ruihan Zhang; Jinya Yin; Haiyan Li; Yiming Yang; Hong Liu; Jiwen Zhang; Haiyan Zhang; Ao Zhang; Hualiang Jiang; Cheng Luo; Cai-Guang Yang
Journal:  J Am Chem Soc       Date:  2012-10-17       Impact factor: 15.419

5.  Structural and thermodynamic studies on the interaction of iminium and alkanolamine forms of sanguinarine with hemoglobin.

Authors:  Soumitra Hazra; Gopinatha Suresh Kumar
Journal:  J Phys Chem B       Date:  2014-03-27       Impact factor: 2.991

Review 6.  Serum albumin.

Authors:  T Peters
Journal:  Adv Protein Chem       Date:  1985

7.  Thermodynamics of protein association reactions: forces contributing to stability.

Authors:  P D Ross; S Subramanian
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

8.  Structural basis for inhibition of the fat mass and obesity associated protein (FTO).

Authors:  WeiShen Aik; Marina Demetriades; Muhammad K K Hamdan; Eleanor A L Bagg; Kar Kheng Yeoh; Clarisse Lejeune; Zhihong Zhang; Michael A McDonough; Christopher J Schofield
Journal:  J Med Chem       Date:  2013-04-23       Impact factor: 7.446

9.  Spectroscopic studies on the interaction between riboflavin and albumins.

Authors:  Hongwei Zhao; Min Ge; Zhaoxia Zhang; Wenfeng Wang; Guozhong Wu
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2006-03-10       Impact factor: 4.098

10.  Binding of perfluorocarboxylates to serum albumin: a comparison of analytical methods.

Authors:  Laura A MacManus-Spencer; Monica L Tse; Paul C Hebert; Heather N Bischel; Richard G Luthy
Journal:  Anal Chem       Date:  2010-02-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.